GlassScriptPhysician profile
Danica Stephens
NPI 1821653213
$708.48
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $64.30 · 2021: $217 · 2022: $232 · 2024: $78.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $343.29 | 2021-2022 | |
| Medtronic Vascular, INC. | $101.05 | 2019 | |
| Kerecis Limited | $35.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Corcept Therapeutics | $26.08 | 2021 | |
| Aroa Biosurgery Incorporated | $23.97 | 2024 | |
| Edwards Lifesciences Corporation | $23.23 | 2020 | |
| Seagen INC. | $22.67 | 2020 | |
| Jazz Pharmaceuticals INC. | $22.06 | 2021 | |
| Amarin Pharma, INC. | $20.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.09 | 2021 | |
| Avita Medical Americas, LLC | $19.05 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.40 | 2020 | |
| Janssen Biotech, INC. | $16.56 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danica Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.